Farberg A, Siegel J, Kurley S, Fitzgerald A, Prasai A, Goldberg M, Ibrahim S, Estrada S. Incorporating the 40-gene expression profile (40-GEP) test for poorly differentiated cutaneous squamous cell carcinoma (cSCC) tumors mitigates risk assessment uncertainty from histologic grading. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.3];7(2):s164. Available from: https://jofskin.org/index.php/skin/article/view/2019